BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 19845871)

  • 1. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G; Gambino R; Cassader M
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on non-alcoholic fatty liver disease in children.
    Papandreou D; Rousso I; Mavromichalis I
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease: is bariatric surgery the answer?
    Pillai AA; Rinella ME
    Clin Liver Dis; 2009 Nov; 13(4):689-710. PubMed ID: 19818313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease.
    Tuyama AC; Chang CY
    J Diabetes; 2012 Sep; 4(3):266-80. PubMed ID: 22564417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
    Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E; Olivero G; Anania C; Ferraro F; Pacifico L
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.